Evofem Biosciences, Inc.
EVFM
$0.01
$0.0016.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.54% | -110.31% | -106.13% | -116.72% | -116.97% |
| Total Depreciation and Amortization | 101.92% | 536.25% | 534.27% | 50.52% | -40.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.02% | 97.57% | 92.66% | 105.05% | 97.41% |
| Change in Net Operating Assets | -69.38% | -73.37% | -66.26% | -81.66% | 52.34% |
| Cash from Operations | -169.03% | -47.13% | 11.70% | 56.68% | 89.26% |
| Capital Expenditure | 85.71% | 85.71% | 100.00% | -250.00% | 64.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 79.76% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 79.92% | -4,285.71% | -3,980.00% | -14,125.00% | -1,241.03% |
| Total Debt Issued | 262.32% | -27.98% | -90.08% | -92.96% | -88.54% |
| Total Debt Repaid | -33.63% | 35.18% | 20.54% | 32.24% | 33.10% |
| Issuance of Common Stock | 4,210.34% | 3,746.15% | 2,083.41% | 1,624.14% | -33.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -200.00% | -- | -- | -- |
| Cash from Financing | 87.51% | 62.78% | 45.69% | -3.37% | -58.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.18% | 0.00% | 149.70% | 103.84% | 103.31% |